Docetaxel Anhydrous
Product Images NDC 71288-151

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Docetaxel Anhydrous (NDC 71288-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – Docetaxel Injection, Usp 16 mL Carton (160mg Cart Np)

FDA Label Image

Principal Display Panel – Docetaxel Injection, Usp 16 mL Vial Label (160mg Vial Np)

FDA Label Image

Principal Display Panel – Docetaxel Injection, Usp 2 mL Carton (20mg Cart Np)

Principal Display Panel – Docetaxel Injection, Usp 2 mL Carton (20mg Cart Np)
This document appears to be a pharmaceutical company's product labeling for their Docetaxel Injection, a cytotoxic agent that is administered intravenously as a single-dose vial. The labeling includes warnings and dosage instructions, and recommends keeping the container away from natural rubber latex and out of reach of children. It also summarizes information about storage conditions and tells pharmacists to discard any unused medication.*
FDA Label Image

Principal Display Panel – Docetaxel Injection, Usp 2 mL Vial Label (20mg Vial Np)

Principal Display Panel – Docetaxel Injection, Usp 2 mL Vial Label (20mg Vial Np)
This is a description for a medication called Docetaxel injection, used for intravenous use only as a cytotoxic agent. It comes in a 2 mL single-dose vial with 20 mg dosage. Any unused portion should be discarded. The medication is a one-vial formulation and is ready to add to the infusion solution. The package insert should be consulted for complete instructions. The medication is produced by a company called novaplus™ located in Chicago, USA.*
FDA Label Image

Principal Display Panel – Docetaxel Injection, Usp 8 mL Carton (80mg Cart Np)

FDA Label Image

Principal Display Panel – Docetaxel Injection, Usp 8 mL Vial Label (80mg Vial Np)

FDA Label Image

Docetaxel Structural Formula (Doc09 0000 01)

FDA Label Image

Figure 1 (Doc09 0000 02)

FDA Label Image

Figure 2 (Doc09 0000 03)

FDA Label Image

Figure 3 (Doc09 0000 04)

FDA Label Image

Figure 4 (Doc09 0000 05)

Figure 4 (Doc09 0000 05)
The text describes a graph or chart related to "CUMULATIVE PROBABILITY" with a Y-axis featuring the title "SURVIVAL TIME (MONTHS)" and an X-axis, which is not shown or legible. However, the text is incomplete and lacks any further details, making it difficult to interpret.*
FDA Label Image

Figure 5 (Doc09 0000 06)

FDA Label Image

Figure 6 (Doc09 0000 07)

FDA Label Image

Figure 7 (Doc09 0000 08)

FDA Label Image

Figure 8 (Doc09 0000 09)

FDA Label Image

Figure 9 (Doc09 0000 10)

FDA Label Image

Figure 10 (Doc09 0000 11)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.